Data_Sheet_1_Xeroderma Pigmentosum C (XPC) Mutations in Primary Fibroblasts Impair Base Excision Repair Pathway and Increase Oxidative DNA Damage.docx
Xeroderma Pigmentosum C (XPC) is a multi-functional protein that is involved not only in the repair of bulky lesions, post-irradiation, via nucleotide excision repair (NER) per se but also in oxidative DNA damage mending. Since base excision repair (BER) is the primary regulator of oxidative DNA damage, we characterized, post-Ultraviolet B-rays (UVB)-irradiation, the detailed effect of three different XPC mutations in primary fibroblasts derived from XP-C patients on mRNA, protein expression and activity of different BER factors. We found that XP-C fibroblasts are characterized by downregulated expression of different BER factors including OGG1, MYH, APE1, LIG3, XRCC1, and Polβ. Such a downregulation was also observed at OGG1, MYH, and APE1 protein levels. This was accompanied with an increase in DNA oxidative lesions, as evidenced by 8-oxoguanine levels, immediately post-UVB-irradiation. Unlike in normal control cells, these oxidative lesions persisted over time in XP-C cells having lower excision repair capacities. Taken together, our results indicated that an impaired BER pathway in XP-C fibroblasts leads to longer persistence and delayed repair of oxidative DNA damage. This might explain the diverse clinical phenotypes in XP-C patients suffering from cancer in both photo-protected and photo-exposed areas. Therapeutic strategies based on reinforcement of BER pathway might therefore represent an innovative path for limiting the drawbacks of NER-based diseases, as in XP-C case.
History
References
- https://doi.org//10.1016/j.redox.2017.11.008
- https://doi.org//10.1111/j.1523-1747.1998.00173.x
- https://doi.org//10.1016/j.freeradbiomed.2013.03.026
- https://doi.org//10.1038/nrc1253
- https://doi.org//10.1136/jmg.2010.083022
- https://doi.org//10.1158/0008-5472.CAN-08-3943
- https://doi.org//10.1128/MCB.00134-15
- https://doi.org//10.1562/0031-8655(200)4079<0145:ucpddn<2.0.co;2
- https://doi.org//10.1038/nature05978
- https://doi.org//10.1016/j.mrfmmm.2004.11.013
- https://doi.org//10.1093/carcin/21.3.453
- https://doi.org//10.1016/j.mrfmmm.2016.01.004
- https://doi.org//10.3109/10715762.2011.647009
- https://doi.org//10.1016/j.dnarep.2008.06.009
- https://doi.org//10.1038/sj.emboj.7601277
- https://doi.org//10.1038/jid.2011.426
- https://doi.org//10.3390/ijms140612222
- https://doi.org//10.1073/pnas.1519444113
- https://doi.org//10.3390/ijms131114766
- https://doi.org//10.1016/j.redox.2018.06.002
- https://doi.org//10.1038/cr.2008.8
- https://doi.org//10.1073/pnas.0503133102
- https://doi.org//10.1038/jid.2014.365
- https://doi.org//10.1038/jid.2014.511
- https://doi.org//10.1074/jbc.M508772200
- https://doi.org//10.1158/1078-0432.CCR-05-0024
- https://doi.org//10.3390/molecules22030356
- https://doi.org//10.1093/carcin/bgi204
- https://doi.org//10.1101/cshperspect.a012583
- https://doi.org//10.1186/1750-1172-6-70
- https://doi.org//10.1093/toxsci/kfq113
- https://doi.org//10.1006/meth.2001.1262
- https://doi.org//10.1016/j.dnarep.2013.08.019
- https://doi.org//10.1089/ars.2012.5036
- https://doi.org//10.1158/0008-5472.CAN-07-6067
- https://doi.org//10.1083/jcb.201205149
- https://doi.org//10.1158/0008-5472.CAN-06-3844
- https://doi.org//10.1186/s40164-016-0035-4
- https://doi.org//10.1016/j.dnarep.2015.09.004
- https://doi.org//10.1074/jbc.M004085200
- https://doi.org//10.3390/ijms17111840
- https://doi.org//10.1093/nar/gki518
- https://doi.org//10.1016/j.freeradbiomed.2019.08.010
- https://doi.org//10.1016/s1011-1344(01)00206-8
- https://doi.org//10.1172/JCI40087
- https://doi.org//10.1074/jbc.M600536200
- https://doi.org//10.1007/s00403-012-1299-0
- https://doi.org//10.1111/bjd.12523
- https://doi.org//10.1038/jid.2009.409
- https://doi.org//10.1016/j.redox.2018.101084
- https://doi.org//10.1101/mcs.a003681
- https://doi.org//10.1155/2018/9147326
- https://doi.org//10.1016/j.ebiom.2017.04.022
- https://doi.org//10.1016/j.freeradbiomed.2011.01.027
- https://doi.org//10.1093/carcin/bgn033
- https://doi.org//10.1016/j.mrrev.2019.108286
- https://doi.org//10.1016/j.jgg.2015.09.006
- https://doi.org//10.1093/emboj/20.4.914
Usage metrics
Read the peer-reviewed publication
Categories
- Gene and Molecular Therapy
- Biomarkers
- Genetics
- Genetically Modified Animals
- Developmental Genetics (incl. Sex Determination)
- Epigenetics (incl. Genome Methylation and Epigenomics)
- Gene Expression (incl. Microarray and other genome-wide approaches)
- Livestock Cloning
- Genome Structure and Regulation
- Genetic Engineering
- Genomics